Inverse relationship between platelet Akt activity and hippocampal atrophy: A pilot case-control study in patients with diabetes mellitus.

Akt Diabetes mellitus Hippocampal atrophy Magnetic resonance imaging Platelet

Journal

World journal of clinical cases
ISSN: 2307-8960
Titre abrégé: World J Clin Cases
Pays: United States
ID NLM: 101618806

Informations de publication

Date de publication:
16 Jan 2024
Historique:
received: 20 10 2023
revised: 15 12 2023
accepted: 21 12 2023
medline: 5 2 2024
pubmed: 5 2 2024
entrez: 5 2 2024
Statut: ppublish

Résumé

Akt plays diverse roles in humans. It is involved in the pathogenesis of type 2 diabetes mellitus (T2DM), which is caused by insulin resistance. Akt also plays a vital role in human platelet activation. Furthermore, the hippocampus is closely associated with memory and learning, and a decrease in hippocampal volume is reportedly associated with an insulin-resistant phenotype in T2DM patients without dementia. To investigate the relationship between Akt phosphorylation in unstimulated platelets and the hippocampal volume in T2DM patients. Platelet-rich plasma (PRP) was prepared from the venous blood of patients with T2DM or age-matched controls. The pellet lysate of the centrifuged PRP was subjected to western blotting to analyse the phosphorylation of Akt, p38 mitogen-activated protein (MAP) kinase and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Phosphorylation levels were quantified by densitometric analysis. Hippocampal volume was analysed using a voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging, which proposes the Z-score as a parameter that reflects hippocampal volume. The levels of phosphorylated Akt corrected with phosphorylated p38 MAP kinase were inversely correlated with the Z-scores in the T2DM subjects, whereas the levels of phosphorylated Akt corrected with GAPDH were not. However, this relationship was not observed in the control patients. These results suggest that an inverse relationship may exist between platelet Akt activation and hippocampal atrophy in T2DM patients. Our findings provide insight into the molecular mechanisms underlying T2DM hippocampal atrophy.

Sections du résumé

BACKGROUND BACKGROUND
Akt plays diverse roles in humans. It is involved in the pathogenesis of type 2 diabetes mellitus (T2DM), which is caused by insulin resistance. Akt also plays a vital role in human platelet activation. Furthermore, the hippocampus is closely associated with memory and learning, and a decrease in hippocampal volume is reportedly associated with an insulin-resistant phenotype in T2DM patients without dementia.
AIM OBJECTIVE
To investigate the relationship between Akt phosphorylation in unstimulated platelets and the hippocampal volume in T2DM patients.
METHODS METHODS
Platelet-rich plasma (PRP) was prepared from the venous blood of patients with T2DM or age-matched controls. The pellet lysate of the centrifuged PRP was subjected to western blotting to analyse the phosphorylation of Akt, p38 mitogen-activated protein (MAP) kinase and glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Phosphorylation levels were quantified by densitometric analysis. Hippocampal volume was analysed using a voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging, which proposes the Z-score as a parameter that reflects hippocampal volume.
RESULTS RESULTS
The levels of phosphorylated Akt corrected with phosphorylated p38 MAP kinase were inversely correlated with the Z-scores in the T2DM subjects, whereas the levels of phosphorylated Akt corrected with GAPDH were not. However, this relationship was not observed in the control patients.
CONCLUSION CONCLUSIONS
These results suggest that an inverse relationship may exist between platelet Akt activation and hippocampal atrophy in T2DM patients. Our findings provide insight into the molecular mechanisms underlying T2DM hippocampal atrophy.

Identifiants

pubmed: 38313640
doi: 10.12998/wjcc.v12.i2.302
pmc: PMC10835682
doi:

Types de publication

Journal Article

Langues

eng

Pagination

302-313

Informations de copyright

©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: The authors declare no conflict of interest.

Auteurs

Haruhiko Tokuda (H)

Department of Metabolic Research, Research Institute, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.
Department of Clinical Laboratory, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.
Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan. tokuda@ncgg.go.jp.

Takamitsu Hori (T)

Department of Metabolic Research, Research Institute, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.
Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.

Daisuke Mizutani (D)

Department of Metabolic Research, Research Institute, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.
Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.

Tomoyuki Hioki (T)

Department of Metabolic Research, Research Institute, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.
Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
Department of Dermatology, Central Japan International Medical Center, Minokamo 505-8510, Japan.

Kumi Kojima (K)

Department of Metabolic Research, Research Institute, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.

Takashi Onuma (T)

Department of Anesthesiology and Pain Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.

Yukiko Enomoto (Y)

Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.

Tomoaki Doi (T)

Department of Metabolic Research, Research Institute, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.
Department of Emergency Medicine, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan.
Department of Emergency and Disaster Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.

Rie Matsushima-Nishiwaki (R)

Department of Metabolic Research, Research Institute, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.
Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.

Shinji Ogura (S)

Department of Emergency and Disaster Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.

Hiroki Iida (H)

Department of Anesthesiology and Pain Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.

Toru Iwama (T)

Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.

Takashi Sakurai (T)

Research Institute, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.

Osamu Kozawa (O)

Department of Metabolic Research, Research Institute, National Center for Geriatrics and Gerontology, Obu 474-8511, Japan.
Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.

Classifications MeSH